tiprankstipranks
Trending News
More News >

ALX Oncology price target lowered to $1 from $1.20 at UBS

UBS lowered the firm’s price target on ALX Oncology (ALXO) to $1 from $1.20 and keeps a Buy rating on the shares.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue